
This report presents a guide to selecting high-quality commercial antibodies against DYRK1A in Western blot and immunoprecipitation using a knockdown cell line as negative control. This study was funded in part by the Simons Foundation Autism Research Initiative (SFARI), an organization that funds innovative research to enhance the understanding, diagnosis and treatment of autism spectrum disorders.
Dual specificity tyrosine-phosphorylation-regulated kinase 1A, antibody characterization, DYRK1A, Q13627, antibody validation
Dual specificity tyrosine-phosphorylation-regulated kinase 1A, antibody characterization, DYRK1A, Q13627, antibody validation
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
